Skip to content
Screener

Karyopharm Therapeutics KPTI Q1 2025 earnings

Reported May 12, 2025 · After market close

Revenue$30.0MMiss by $5.1M
EPS-$2.77Beat by $1.44
Revenue estimate$35.1M
EPS estimate-$4.21

Next report

Nov 2, 2026 (in a month)
Revenue estimate$33.5M
EPS estimate-$1.16

FAQ

When did Karyopharm Therapeutics report Q1 2025 earnings?
Karyopharm Therapeutics (KPTI) reported Q1 2025 earnings on May 12, 2025 after market close.
What were Karyopharm Therapeutics's Q1 2025 revenue and EPS?
Karyopharm Therapeutics reported revenue of $30.0M and eps of $-2.77 for Q1 2025.
Did Karyopharm Therapeutics beat estimates in Q1 2025?
Revenue missed the consensus estimate of $35.1M by $5.1M. EPS beat the consensus estimate of $-4.21 by $1.44.
How did Karyopharm Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 9.4% from $33.1M a year earlier and eps grew 42.3% from $-4.80.
Where can I find Karyopharm Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-069176) and the 10-Q periodic report (0000950170-25-069231) directly on SEC EDGAR. The filing index links above go to sec.gov.